Medical Cannabis News

Synonyms: 
mmj
Thu
19
Apr

Medical marijuana in Louisiana could be ready by fall 2018

Medical marijuana products could be available to Louisiana patients as early as September — 40 years after state lawmakers first approved marijuana for medical use.

Officials from Louisiana State University and Southern University — the stewards of the state crops to be processed into marijuana-based medicines — presented rough timelines and budgets to the joint House and Senate agriculture committee April 18, the same week the Louisiana Board of Pharmacy awarded competitive, potentially lucrative licenses to nine medical marijuana pharmacies that will cover the entire state.

Thu
19
Apr

A shocking number of doctors on board with New York marijuana

Latest survey of NY physicians reveals widespread support for cannabis.

Doctors in New York overwhelmingly support medical marijuana, according to a recent survey. According to a study published in the journal Cannabis and Cannabinoid Research, 71 percent of NY physicians agree that cannabis should be a therapeutic option available to qualifying patients.

Thu
19
Apr

Canada: Reasons unclear for ban on mixing caffeine and cannabis

One research scientist speculated the ban could mean the government wishes to avoid commercial production of highly-caffeinated energy drinks laced with THC, the psychoactive compound found in cannabis.

A government prohibition against mixing cannabis and caffeine makes little sense, say some research scientists. There is only speculation that the combination might pose a risk.

The practice, so common in the legendary pot capital of Amsterdam that cannabis dispensaries are called “coffee shops,” appears unlikely to be coming to Canada anytime soon.

Wed
18
Apr

Replacing alcohol with marijuana may prevent dementia

While alcohol is one of America’s favorite inebriating substances, it also puts users at a greater risk for dementia, according to a new study from the Centre for Addiction and Mental Health.

In the report, researchers said that alcohol was one of the most preventable risk factors in the development of nearly every type of dementia, including early onset. The consensus is that tens of thousands of people every year could be saved from this deadly disease if they could just find a way to curb their booze consumption.

Wed
18
Apr

Could this be the first cannabis-based drug to get FDA approval?

The first cannabis-based drug to get FDA approval could be a strawberry-flavored, oral CBD solution designed for kids with epilepsy.

Nearly a year ago, UK drug manufacturer GW Pharmaceuticals filed its breakthrough epilepsy treatment for approval by U.S. regulators.

The drug, Epidiolex, is derived from cannabidiol, or CBD, a non-psychoactive constituent of the cannabis plant. And on Tuesday, the FDA issued a report citing the “substantial evidence” GW Pharma had provided on the drug’s effectiveness. Could Epidiolex be the first cannabis-based drug to get FDA Approval?

Epidiolex: The cannabis-based drug that can beat epilepsy

Wed
18
Apr

New Orleans is about to get its first medical marijuana dispensary

After Louisiana’s Pharmacy Board rejected its own subcommittee’s recommendation, New Orleans is about to get its first medical marijuana dispensary.

The Big Easy is about to pass a major milestone in the ongoing expansion of Louisiana’s medical marijuana program. Thanks to a come from behind victory from the second-generation owner of a father-son pharmacy that’s been in business since the sixties, New Orleans is about to get its first medical marijuana dispensary.

Louisiana awards dispensary permit to New Orleans pharmacist with roots in the community

Wed
18
Apr

Medical marijuana will arrive in Israeli pharmacies in time for 4/20

Select Israeli pharmacies will begin selling medical marijuana... on April 20, of course.

Instead of teenagers smoking after school at 4:20 p.m. or activists waiting until April 20 (4/20 by American date notation), nearly two dozen Israeli pharmacies will start selling medical marijuana on that date this Friday – known worldwide as a day on which advocates for legalization light up in public. As part of a pilot program, 21 Super-Pharm outlets plan to sell medical cannabis oil in cities throughout the country, with the exception of Tel Aviv and Eilat.

Two other private pharmacies plan to participate but are not expected to start selling this week, while the four Israeli health fund pharmacies are not interested in providing medical marijuana – for now.

Tue
17
Apr

Strainprint™ Technologies Ltd. welcomes three leading cannabinoid physicians to its board

Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely with its medical advisors to support patients, enhance research and to advance the scientific understanding of cannabinoid therapy.

With over 400,000 medical records and almost 7 million data points, and growing, Strainprint is the most trusted source for strain efficacy and patient use data. Dr. MacCallum and Dr. Schecter will jointly lead Strainprint's Medical Advisory Board as Co-chairs and Dr. Elterman will focus on specific cannabinoid studies through the University Health Network.

Tue
17
Apr

Medical marijuana push spreads to Utah, Oklahoma

The push for legalized marijuana has moved into Utah and Oklahoma, two of the most conservative states in the country, further underscoring how quickly feelings about marijuana are changing in the United States. If the two measures pass, Utah and Oklahoma will join 30 other states that have legalized some form of medical marijuana, according to the pro-pot National Organization for the Reform of Marijuana laws.

Nine of those states and Washington, D.C. also have broad legalization where adults 21 and older can use pot for any reason. Michigan could become the 10th state with its ballot initiative this year.

Tue
17
Apr

Trump Tuesday: Experts react to Donald Trump’s action to protect medical marijuana

Wondering how experts react to Donald Trump’s action to protect medical marijuana? We talked to a few.​

In the hours since news broke that President Donald Trump struck a tentative deal with Sen. Cory Gardner (R-CO) over future legislation protecting states that have legalized marijuana from federal intervention, there’s been a lot of feedback from advocates and political analysts. 

Experts react to Donald Trump’s action to protect medical marijuana…and not all are eager to show optimism.

Roger Stone Reacts

Pages

Subscribe to RSS - Medical Cannabis News